Herbert H. Schneider

2.4k total citations
48 papers, 2.0k citations indexed

About

Herbert H. Schneider is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Herbert H. Schneider has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 9 papers in Pharmacology. Recurrent topics in Herbert H. Schneider's work include Neuroscience and Neuropharmacology Research (22 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Receptor Mechanisms and Signaling (7 papers). Herbert H. Schneider is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Receptor Mechanisms and Signaling (7 papers). Herbert H. Schneider collaborates with scholars based in Germany, Ireland and United States. Herbert H. Schneider's co-authors include David Stephens, Ralph Schmiechen, W. Kehr, Martin Sarter, Nikolaus Seiler, Leif H. Jensen, Erling N. Petersen, Maurice M. Rapport, Liselotte Graf and L. Turski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Trends in Neurosciences.

In The Last Decade

Herbert H. Schneider

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert H. Schneider Germany 26 969 966 342 316 252 48 2.0k
M.C. Dubroeucq France 18 1.4k 1.4× 925 1.0× 220 0.6× 261 0.8× 185 0.7× 24 2.0k
Vimala H. Sethy United States 25 1.2k 1.2× 834 0.9× 257 0.8× 394 1.2× 412 1.6× 70 2.2k
W.P. Burkard Switzerland 27 1.2k 1.3× 826 0.9× 196 0.6× 351 1.1× 198 0.8× 63 2.3k
C. Guérémy France 25 1.7k 1.8× 1.3k 1.3× 265 0.8× 160 0.5× 342 1.4× 51 2.6k
A. S. Horn Netherlands 19 1.2k 1.2× 771 0.8× 148 0.4× 183 0.6× 136 0.5× 44 1.8k
Soumen Paul United States 24 1.6k 1.6× 983 1.0× 321 0.9× 166 0.5× 141 0.6× 48 2.7k
A. Uzan France 26 1.8k 1.9× 1.4k 1.4× 272 0.8× 183 0.6× 267 1.1× 77 3.0k
R. M. Marchbanks United Kingdom 30 1.5k 1.6× 1.3k 1.4× 351 1.0× 422 1.3× 106 0.4× 70 2.6k
László G. Hársing Hungary 30 1.6k 1.7× 1.2k 1.3× 285 0.8× 224 0.7× 138 0.5× 138 2.7k
Andre I. Salama United States 25 1.2k 1.2× 906 0.9× 146 0.4× 193 0.6× 178 0.7× 73 1.9k

Countries citing papers authored by Herbert H. Schneider

Since Specialization
Citations

This map shows the geographic impact of Herbert H. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert H. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert H. Schneider more than expected).

Fields of papers citing papers by Herbert H. Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert H. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert H. Schneider. The network helps show where Herbert H. Schneider may publish in the future.

Co-authorship network of co-authors of Herbert H. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert H. Schneider. A scholar is included among the top collaborators of Herbert H. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert H. Schneider. Herbert H. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steuer, Heiko, Andreas Jaworski, Bernd Elger, et al.. (2005). Functional Characterization and Comparison of the Outer Blood–Retina Barrier and the Blood–Brain Barrier. Investigative Ophthalmology & Visual Science. 46(3). 1047–1047. 110 indexed citations
2.
3.
Tortarolo, Massimo, Giuliano Grignaschi, Novella Calvaresi, et al.. (2005). Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. Journal of Neuroscience Research. 83(1). 134–146. 90 indexed citations
4.
Dinter, Harald, Jenny Tse, Meredith Halks‐Miller, et al.. (2000). The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. Journal of Neuroimmunology. 108(1-2). 136–146. 43 indexed citations
5.
Turski, Lechosław, Andreas Huth, Malcolm J. Sheardown, et al.. (1998). ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proceedings of the National Academy of Sciences. 95(18). 10960–10965. 128 indexed citations
6.
Schneider, Herbert H., et al.. (1993). Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.. Journal of Pharmacology and Experimental Therapeutics. 264(3). 1395–1400. 39 indexed citations
7.
Pribilla, I., et al.. (1993). Abecarnil is a Full Agonist at Some, and a Partial Agonist at Other Recombinant GABAA Receptor Subtypes. PubMed. 11. 50–61. 28 indexed citations
8.
Schmiechen, Ralph, Herbert H. Schneider, & H. Wachtel. (1990). Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase. Psychopharmacology. 102(1). 17–20. 52 indexed citations
9.
Turski, L., David Stephens, Leif H. Jensen, et al.. (1990). Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 344–352. 74 indexed citations
10.
Schneider, Herbert H. & David Stephens. (1988). Co-existence of kindling induced by the β-carboline, FG 7142, and tolerance to diazepam following chronic treatment in mice. European Journal of Pharmacology. 154(1). 35–45. 14 indexed citations
11.
Stephens, David, Herbert H. Schneider, W. Kehr, et al.. (1987). Modulation of anxiety by β-carbolines and other benzodiazepine receptor ligands: Relationship of pharmacological to biochemical measures of efficacy. Brain Research Bulletin. 19(3). 309–318. 68 indexed citations
12.
Schneider, Herbert H., et al.. (1986). Stereospecific binding of the antidepressant rolipram to brain protein structures. European Journal of Pharmacology. 127(1-2). 105–115. 205 indexed citations
13.
Löscher, Wolfgang, Herbert H. Schneider, & W. Kehr. (1985). Evaluation of different β-carbolines in Mongolian gerbils with reflex epilepsy. European Journal of Pharmacology. 114(3). 261–266. 13 indexed citations
14.
Schneider, Herbert H.. (1984). Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochemical Pharmacology. 33(10). 1690–1693. 84 indexed citations
15.
Stephens, David, W. Kehr, Herbert H. Schneider, & Ralph Schmiechen. (1984). β-Carbolines with agonistic and inverse agonistic properties at benzodiazepine receptors of the rat. Neuroscience Letters. 47(3). 333–338. 45 indexed citations
16.
Schneider, Herbert H., et al.. (1980). Molecular aspects of albumin functions: indications for its use in plasma substitution.. PubMed. 48. 31–42. 5 indexed citations
17.
Seiler, Nikolaus & Herbert H. Schneider. (1974). Estimation of picomole quantities of piperidine in tissues. Journal of Mass Spectrometry. 1(6). 381–385. 29 indexed citations
18.
Schneider, Herbert H., et al.. (1971). Separation of 1-dimethylamino-naphthalene-5-sulphonylamides by gel chromatography. Journal of Chromatography A. 59(2). 367–371. 8 indexed citations
19.
Seiler, Nikolaus, et al.. (1970). Massenspektrometrische Identifizierung von biogenen Aminen in Form ihrer 1-Dimethylamino-naphthalin-5-sulfonyl-Derivate. Fresenius Zeitschrift für Analytische Chemie. 252(2-3). 127–136. 48 indexed citations
20.
Schoen, Robert T. & Herbert H. Schneider. (1953). Can Treatment of Tapeworm Infections be Harmless. DMW - Deutsche Medizinische Wochenschrift. 78. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Dubroeucq Breakdown of academic impact, for papers by Vimala H. Sethy Breakdown of academic impact, for papers by W.P. Burkard Breakdown of academic impact, for papers by C. Guérémy Breakdown of academic impact, for papers by A. S. Horn Breakdown of academic impact, for papers by Soumen Paul Breakdown of academic impact, for papers by A. Uzan Breakdown of academic impact, for papers by R. M. Marchbanks Breakdown of academic impact, for papers by László G. Hársing Breakdown of academic impact, for papers by Andre I. Salama
Rankless by CCL
2026